Literature DB >> 32083651

Whole-genome analysis of vancomycin-resistant Enterococcus faecium causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavaria, Germany.

David Eisenberger1, Christian Tuschak2, Markus Werner3, Christian Bogdan3, Thomas Bollinger4, Hamid Hossain5,6, Petra Friedrich7, Ziyad Hussein8, Christoph Pöhlmann9, Benjamin Würstl10, Silke Nickel1, Verena Lehner-Reindl1, Christiane Höller2, Bernhard Liebl2, Giuseppe Valenza1,3.   

Abstract

OBJECTIVES: Infections caused by vancomycin-resistant Enterococcus faecium (VREfm) represent a major public health concern due to limited treatment options. Among invasive isolates of VREfm, ST117, ST80 and ST78 represent the most frequently detected STs by MLST in Germany. In this study, we investigated the genetic diversity of isolates of VREfm recovered from different nosocomial outbreaks in Bavaria, Germany, by WGS.
METHODS: Between January 2018 and April 2019, 99 non-replicate isolates of VREfm originating from nosocomial outbreaks at eight different hospitals in Bavaria were investigated for genetic diversity by WGS. In detail, complex types (CTs) were identified by core-genome MLST. Furthermore, an SNP analysis was performed for all VREfm strains.
RESULTS: Most of the isolates of this study (76%) belonged to three major clonal groups, which occurred in at least three hospitals: ST80/CT1065 vanB (n = 45; six hospitals), ST117/CT71 vanB (n = 11; four hospitals) and ST78/CT894like vanA (n = 19; three hospitals). Moreover, isolates of the predominant lineage ST80/CT1065 vanB showed a maximum difference of 36 SNPs as revealed by SNP analysis.
CONCLUSIONS: Whole-genome analysis of VREfm causing nosocomial outbreaks suggests the occurrence of few endemic clonal lineages in Bavarian hospital settings, namely ST80/CT1065 vanB, ST117/CT71 vanB and ST78/CT894like vanA. Further studies are needed for a better understanding of the factors affecting the successful spread of the above-mentioned lineages.
© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32083651     DOI: 10.1093/jac/dkaa041

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  5 in total

1.  Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019.

Authors:  Michaël Timmermans; Bert Bogaerts; Kevin Vanneste; Sigrid C J De Keersmaecker; Nancy H C Roosens; Carole Kowalewicz; Guillaume Simon; Maria A Argudín; Ariane Deplano; Marie Hallin; Pierre Wattiau; David Fretin; Olivier Denis; Cécile Boland
Journal:  J Antimicrob Chemother       Date:  2021-12-24       Impact factor: 5.790

2.  The Role of Whole Genome Sequencing in the Surveillance of Antimicrobial Resistant Enterococcus spp.: A Scoping Review.

Authors:  Lindsay A Rogers; Kayla Strong; Susan C Cork; Tim A McAllister; Karen Liljebjelke; Rahat Zaheer; Sylvia L Checkley
Journal:  Front Public Health       Date:  2021-06-10

3.  Molecular Epidemiology of Vancomycin-Resistant Enterococci Bloodstream Infections in Germany: A Population-Based Prospective Longitudinal Study.

Authors:  Carlos L Correa-Martínez; Annette Jurke; Janne Schmitz; Frieder Schaumburg; Stefanie Kampmeier; Alexander Mellmann
Journal:  Microorganisms       Date:  2022-01-08

4.  Epidemiological and genetic characteristics of vancomycin-resistant Enterococcus faecium isolates in a University Children's Hospital in Germany: 2019 to 2020.

Authors:  Ilona Trautmannsberger; Laura Kolberg; Melanie Meyer-Buehn; Johannes Huebner; Guido Werner; Robert Weber; Valerie Heselich; Sebastian Schroepf; Hans-Georg Muench; Ulrich von Both
Journal:  Antimicrob Resist Infect Control       Date:  2022-03-12       Impact factor: 4.887

5.  Changing epidemiology of vancomycin-resistant Enterococcus faecium: Results of a genome-based study at a regional neurological acute hospital with intensive care and early rehabilitation treatment.

Authors:  Linda Falgenhauer; Ingeborg Preuser; Can Imirzalioglu; Jane Falgenhauer; Moritz Fritzenwanker; Dietrich Mack; Christoph Best; Ursel Heudorf; Trinad Chakraborty
Journal:  Infect Prev Pract       Date:  2021-03-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.